Pancreatic Cancer Research

ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed

Antonio Jimeno

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8560-0440; OpenAlex author ID A5007992309, A5107936741. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: none · 2014: none · 2015: 2 papers

Papers 6

  1. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreate… Co-author DOI 10.1093/annonc/mdv264↗
  2. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreate… Co-author DOI 10.1093/annonc/mdv477↗
  3. Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. Co-author DOI 10.1007/s10637-012-9818-6↗
  4. Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with soli… Last author DOI 10.1158/1078-0432.ccr-11-2813↗
  5. Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer. Co-author DOI 10.1007/s10637-010-9413-7↗
  6. Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic … Co-author DOI 10.1158/1078-0432.ccr-11-0341↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wells A. Messersmith · 4 shared papers, 2011–2015 · strength 0.12
  2. Manuel M. Hidalgo · 3 shared papers, 2011–2012 · strength 0.07
  3. Daniel A. Laheru · 3 shared papers, 2011–2012 · strength 0.07
  4. Deirdre Jill Cohen · 2 shared papers, 2015 · strength 0.07
  5. Bert H. O’Neil · 2 shared papers, 2015 · strength 0.07
  6. Mike Cusnir · 2 shared papers, 2015 · strength 0.07
  7. Olugbenga Olanrele Olowokure · 2 shared papers, 2015 · strength 0.07
  8. Jordan D. Berlin · 2 shared papers, 2015 · strength 0.07
  9. Aaron James Scott · 2 shared papers, 2015 · strength 0.07
  10. Steven J. Cohen · 2 shared papers, 2015 · strength 0.07
  11. Autumn J. McRee · 2 shared papers, 2015 · strength 0.07
  12. Colin D. Weekes · 2 shared papers, 2011–2012 · strength 0.05
  13. Ross C. Donehower · 2 shared papers, 2011–2012 · strength 0.05
  14. N.V. Rajeshkumar · 2 shared papers, 2011–2012 · strength 0.05
  15. Lawrence Leichman · 1 shared paper, 2015 · strength 0.03
  16. Alex A. Adjei · 1 shared paper, 2012 · strength 0.03
  17. Wen Wee Ma · 1 shared paper, 2012 · strength 0.03
  18. Dung Thi Le · 1 shared paper, 2012 · strength 0.03
  19. Ming Zhao · 1 shared paper, 2012 · strength 0.03
  20. Florencia M. McAllister · 1 shared paper, 2012 · strength 0.03
  21. Anirban Maitra · 1 shared paper, 2011 · strength 0.02
  22. Ralph H. Hruban · 1 shared paper, 2011 · strength 0.02
  23. Ignacio Garrido‐Laguna · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.